Detection and localization of early- and late-stage cancers using platelet RNA
- PMID: 36055228
- DOI: 10.1016/j.ccell.2022.08.006
Detection and localization of early- and late-stage cancers using platelet RNA
Abstract
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for cancer detection, as they alter their RNA content upon local and systemic cues. We show that tumor-educated platelet (TEP) RNA-based blood tests enable the detection of 18 cancer types. With 99% specificity in asymptomatic controls, thromboSeq correctly detected the presence of cancer in two-thirds of 1,096 blood samples from stage I-IV cancer patients and in half of 352 stage I-III tumors. Symptomatic controls, including inflammatory and cardiovascular diseases, and benign tumors had increased false-positive test results with an average specificity of 78%. Moreover, thromboSeq determined the tumor site of origin in five different tumor types correctly in over 80% of the cancer patients. These results highlight the potential properties of TEP-derived RNA panels to supplement current approaches for blood-based cancer screening.
Keywords: RNA; TEP; blood; blood platelets; cancer; early detection; liquid biopsy.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests M.G. Best, R.J.A.N., and T.W. are inventors on relevant patent applications (PCT/NL2011/050518 and PCT/NL2018/050110). R.J.A.N. and T.W. are shareholders of Illumina, Inc. M.H. is chief formulation officer at Nurish.Me, Inc., and Camelina Sun LLC and has equity in those companies (whose business activities are unrelated to the present work). D.M.P. and D.K.L. are shareholders of ExBiome BV.
Comment in
-
A new method for early cancer detection based on platelet transcriptomics will have low positive predictive value.Clin Chem Lab Med. 2022 Dec 2;61(6):e85-e86. doi: 10.1515/cclm-2022-1025. Print 2023 May 25. Clin Chem Lab Med. 2022. PMID: 36472964 No abstract available.
Similar articles
-
Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring.Cancer Res. 2018 Jul 1;78(13):3407-3412. doi: 10.1158/0008-5472.CAN-18-0887. Epub 2018 Jun 19. Cancer Res. 2018. PMID: 29921699 Review.
-
Platelet RNA as Pan-Tumor Biomarker for Cancer Detection.Cancer Res. 2020 Apr 1;80(7):1371-1373. doi: 10.1158/0008-5472.CAN-19-3684. Epub 2020 Feb 19. Cancer Res. 2020. PMID: 32075797
-
Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management.Sci Rep. 2023 Jun 8;13(1):9359. doi: 10.1038/s41598-023-35818-w. Sci Rep. 2023. PMID: 37291189 Free PMC article.
-
Development of an accurate breast cancer detection classifier based on platelet RNA.Sci Rep. 2024 Dec 28;14(1):30733. doi: 10.1038/s41598-024-80175-x. Sci Rep. 2024. PMID: 39730431 Free PMC article.
-
Tumor-educated platelet, a potential liquid biopsy biosource in pancreatic cancer: A review.Pathol Res Pract. 2025 Jun;270:155986. doi: 10.1016/j.prp.2025.155986. Epub 2025 Apr 21. Pathol Res Pract. 2025. PMID: 40286788 Review.
Cited by
-
Liquid biopsy: paving a new avenue for cancer research.Cell Adh Migr. 2024 Dec;18(1):1-26. doi: 10.1080/19336918.2024.2395807. Epub 2024 Sep 1. Cell Adh Migr. 2024. PMID: 39219215 Free PMC article. Review.
-
Emerging Role of Tumor-Educated Platelets as a New Liquid Biopsy Tool for Colorectal Cancer.Arch Iran Med. 2023 Aug 1;26(8):447-454. doi: 10.34172/aim.2023.68. Arch Iran Med. 2023. PMID: 38301107 Free PMC article. Review.
-
Assessing the complementary information from an increased number of biologically relevant features in liquid biopsy-derived RNA-Seq data.Heliyon. 2024 Mar 12;10(6):e27360. doi: 10.1016/j.heliyon.2024.e27360. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38515664 Free PMC article.
-
Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment.Front Immunol. 2023 Apr 19;14:1130513. doi: 10.3389/fimmu.2023.1130513. eCollection 2023. Front Immunol. 2023. PMID: 37153569 Free PMC article.
-
Contents in tumor-educated platelets as the novel biosource for cancer diagnostics.Front Oncol. 2023 Apr 17;13:1165600. doi: 10.3389/fonc.2023.1165600. eCollection 2023. Front Oncol. 2023. PMID: 37139159 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases